A discussion of cases in the 2001 RCPA-AQAP chemical pathology case report comments program

被引:9
作者
Lim, EM
Vasikaran, SD
Gill, J
Calleja, J
Hickman, PE
Beilby, J
Penberthy, L
Sikaris, KA
机构
[1] Pathctr, Dept Biochem, Perth, WA, Australia
[2] Royal Perth Hosp, Dept Biochem, Perth, WA 6847, Australia
[3] RCPA AACB Chem Pathol Grp, Adelaide, SA, Australia
[4] Princess Alexandra Hosp, Div Chem Pathol, Brisbane, Qld 4102, Australia
[5] Dorevitch Pathol, Heidelberg, Vic, Australia
关键词
interpretative commenting; quality assurance; continuing education; continuing professional development;
D O I
10.1097/01268031-200335020-00009
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aim: We present a descriptive analysis of the 10 case reports distributed in the Royal College of Pathologists of Australasia (RCPA) and the Australasian Association of Clinical Biochemists (AACB) Chemical Pathology Patient Report Comments Program to assess the quality of interpretative commenting in clinical biochemistry in 2001. Method: Participants were asked to comment on a given set of biochemistry results attached with brief clinical details. All responses received were translated into key phrases and graphically presented on a histogram. An expert panel was asked to evaluate the appropriateness of the key phrases and to propose a suggested composite comment. Results: While the majority of comments received were felt to be acceptable by the expert panel, some comments were felt to be inappropriate or misleading. As comments on laboratory reports may affect clinical management of patients, it is important that these comments reflect accepted practice and current guidelines. Conclusion: The Patient Report Comments Program may play an important role in continuing education and possibly in quality assurance of interpretative commenting.
引用
收藏
页码:145 / 150
页数:6
相关论文
共 9 条
[1]   Audit of investigation of subclinical hypothyroidism in Scottish laboratories [J].
Berry, P .
ANNALS OF CLINICAL BIOCHEMISTRY, 2002, 39 :26-33
[2]   Assessing the quality of comments on reports: a retrospective study [J].
Challand, GS .
ANNALS OF CLINICAL BIOCHEMISTRY, 1999, 36 :316-322
[3]  
*JOINT EUR SOC CAR, 2000, EUR HEART J, V102, P1216
[4]   Provision of interpretative comments on biochemical report forms [J].
Marshall, WJ ;
Challand, GS .
ANNALS OF CLINICAL BIOCHEMISTRY, 2000, 37 :758-763
[5]   TREATMENT GUIDELINES FOR PATIENTS WITH HYPERTHYROIDISM AND HYPOTHYROIDISM [J].
SINGER, PA ;
COOPER, DS ;
LEVY, EG ;
LADENSON, PW ;
BRAVERMAN, LE ;
DANIELS, G ;
GREENSPAN, FS ;
MCDOUGALL, IR ;
NIKOLAI, TF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (10) :808-812
[6]   Subclinical thyroid disease [J].
Surks, MI ;
Ocampo, E .
AMERICAN JOURNAL OF MEDICINE, 1996, 100 (02) :217-223
[7]  
Vanderpump MPJ, 1996, BMJ-BRIT MED J, V313, P539
[8]   Review of a pilot quality-assessment program for interpretative comments [J].
Vasikaran, SD ;
Penberthy, L ;
Gill, J ;
Scott, S ;
Sikaris, KA .
ANNALS OF CLINICAL BIOCHEMISTRY, 2002, 39 :250-260
[9]   Which surrogate marker can be used to assess the effectiveness of the laboratory and its contribution to clinical outcome? [J].
Waise, A ;
Plebani, M .
ANNALS OF CLINICAL BIOCHEMISTRY, 2001, 38 :589-595